PEG-MGDF
Term · Oncology and biomedicine · MLC-T-ONC-006452
A form of megakaryocyte growth and development factor (MGDF) that is made in the laboratory. MGDF comes from the protein thrombopoietin, which is normally made in the body to help make platelets. PEG-MGDF is being studied as a way to increase the number of platelets in patients receiving chemotherapy. Also called PEG-rhMGDF and polyethylene glycosylated recombinant human megakaryocyte growth and development factor.
| Identifier | MLC-T-ONC-006452 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | polyethylene glycosylated recombinant human megakaryocyte growth and development factor |
| Synonyms | PEG-rhMGDF |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-006452",
"term": "PEG-MGDF",
"field": "Oncology and biomedicine",
"definition": "A form of megakaryocyte growth and development factor (MGDF) that is made in the laboratory. MGDF comes from the protein thrombopoietin, which is normally made in the body to help make platelets. PEG-MGDF is being studied as a way to increase the number of platelets in patients receiving chemotherapy. Also called PEG-rhMGDF and polyethylene glycosylated recombinant human megakaryocyte growth and development factor.",
"expansions": [
"polyethylene glycosylated recombinant human megakaryocyte growth and development factor"
],
"synonyms": [
"PEG-rhMGDF"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/peg-mgdf/"
}
Record 12,855 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.